Poongjeon Pharmacy

풍전약품(주) · KOSDAQ · 298060 · Industry: Manufacture of medicaments

Key metrics

Earnings

Revenue, Q3 2026₩10.4bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-13.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoYNot available
Operating income, Q3 2026-₩560m As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+43.2% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoYNot available

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩2.0bn As of Jun 10, 2026 Source 1 ↗
Rights offering new shares, last 12 months1,996,812 shares As of Oct 26, 2026 Source 1 ↗, Source 2
Potential new shares, last 12 months4,463,078 shares (1 upward conversion price adjustment not netted) As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4 ↗, Source 5 ↗ +1 more
Potential new shares, % of shares46.3% (1 upward conversion price adjustment not netted) As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4 ↗, Source 5 ↗ +2 more
Conversion price adjustments, last 12 months4 As of Aug 4, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months10 As of Nov 19, 2026
DART filings, previous 3 months12 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)267,335 shares As of Jun 9, 2026 Source 1 ↗, Source 2 ↗
Open-market buys, last 12 months (amount)₩710m As of Jun 9, 2026 Source 1 ↗, Source 2 ↗
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)267,335 shares As of Jun 9, 2026 Source 1 ↗, Source 2 ↗
Insiders who bought, last 12 months1 As of Jun 9, 2026 Source 1 ↗, Source 2 ↗

Insider transactions (last 12 months)

Open-market buys: 267,335 shares (₩710m). Open-market sells: 0 shares (₩0). Net open-market buying: +267,335 shares. Insiders who bought: 1.

Trade dateInsider (role)TypeSharesPriceAmount
Nov 11, 2026Aria Singisuljohap Je95ho (10%+ shareholder)Other (Other decrease)0 shares——
Nov 11, 2026Yuta Singisuljohap Je82ho (10%+ shareholder)Other (Other decrease)0 shares——
Jun 30, 2026Koni Singisuljohap Je63ho (10%+ shareholder)Other (New report)+429,530 shares₩3,725₩1.6bn
Jun 30, 2026Koni Singisuljohap Je63ho (10%+ shareholder)Other (New report)+432,900 shares₩4,620₩2.0bn
Jun 30, 2026Koni Singisuljohap Je63ho (10%+ shareholder)Other (Third-party placement)+796,812 shares₩2,510₩2.0bn
Jun 9, 2026Kim Yu-jeong (Registered director)Open-market buy+112,711 shares₩2,662₩300m
Jun 8, 2026Kim Yu-jeong (Registered director)Open-market buy+4,624 shares₩2,600₩12m
Jun 5, 2026Kim Yu-jeong (Registered director)Open-market buy+52,649 shares₩2,677₩141m
Jun 4, 2026Kim Yu-jeong (Registered director)Open-market buy+19,000 shares₩2,655₩50m
Jun 2, 2026Kim Yu-jeong (Registered director)Open-market buy+78,351 shares₩2,633₩206m
Apr 24, 2026Mareusia Singisuljohap Je77ho (10%+ shareholder)Other (Reverse split)-9,039,658 shares——
Apr 24, 2026Yuta Singisuljohap Je82ho (10%+ shareholder)Other (Reverse split)-3,651,007 shares——
Apr 24, 2026Aria Singisuljohap Je95ho (10%+ shareholder)Other (Reverse split)-3,787,879 shares——

Annual financials

YearRevenueOperating income
2025₩23.8bn-₩4.5bn
2024₩825m-₩11.3bn
2023₩696m-₩13.0bn

Filing timeline